Putnam Investments LLC Boston Scientific Corp Transaction History

Putnam Investments LLC

$73 Billion
Q4 2023

A detailed history of Putnam Investments LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Putnam Investments LLC holds 13,067,570 shares of BSX stock, worth $1.17 Billion. This represents 1.03% of its overall portfolio holdings.

Number of Shares

13,067,570

Previous 6,208,290 110.49%

Holding current value

$1.17 Billion

Previous $328 Million 130.46%

% of portfolio

1.03%

Previous 0.51%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$48.64 - $57.81 $334 Million - $397 Million	6,859,280 Added 110.49%	13,067,570 $755 Million
Q3 2023 Nov 14, 2023	BUY	$50.19 - $54.68 $111 Million - $121 Million	2,208,182 Added 55.2%	6,208,290 $328 Million
Q2 2023 Aug 14, 2023	SELL	$49.72 - $54.64 $36.9 Million - $40.5 Million	-741,775 Reduced 15.64%	4,000,108 $216 Million
Q1 2023 May 22, 2023	SELL	$45.09 - $50.03 $109 Million - $121 Million	-2,424,319 Reduced 33.83%	4,741,883 $237 Million
Q4 2022 Feb 14, 2023	BUY	$39.56 - $47.22 $96 Million - $115 Million	2,426,304 Added 51.19%	7,166,202 $332 Million
Q3 2022 Nov 14, 2022	BUY	$36.71 - $109.66 $34.8 Million - $104 Million	947,300 Added 24.98%	4,739,898 $184 Million
Q2 2022 Aug 15, 2022	BUY	$35.24 - $47.1 $47.2 Million - $63.1 Million	1,339,432 Added 54.6%	3,792,598 $141 Million
Q1 2022 May 16, 2022	BUY	$40.9 - $45.1 $54 Million - $59.6 Million	1,320,960 Added 116.67%	2,453,166 $109 Million
Q4 2021 Feb 14, 2022	BUY	$38.07 - $44.87 $1.36 Million - $1.61 Million	35,832 Added 3.27%	1,132,206 $48.1 Million
Q3 2021 Nov 15, 2021	BUY	$41.23 - $45.88 $32.3 Million - $35.9 Million	783,538 Added 250.46%	1,096,374 $47.6 Million
Q2 2021 Aug 16, 2021	SELL	$38.58 - $44.24 $3.18 Million - $3.65 Million	-82,487 Reduced 20.87%	312,836 $13.4 Million
Q1 2021 May 17, 2021	SELL	$35.27 - $39.67 $1.84 Million - $2.07 Million	-52,265 Reduced 11.68%	395,323 $15.3 Million
Q4 2020 Feb 16, 2021	SELL	$33.15 - $41.97 $56.5 Million - $71.5 Million	-1,704,484 Reduced 79.2%	447,588 $16.1 Million
Q3 2020 Nov 16, 2020	BUY	$34.44 - $42.23 $6.8 Million - $8.34 Million	197,573 Added 10.11%	2,152,072 $82.2 Million
Q2 2020 Aug 14, 2020	SELL	$30.19 - $39.11 $1.87 Million - $2.42 Million	-61,925 Reduced 3.07%	1,954,499 $68.6 Million
Q1 2020 May 15, 2020	BUY	$25.83 - $45.71 $999,026 - $1.77 Million	38,677 Added 1.96%	2,016,424 $65.8 Million
Q4 2019 Feb 14, 2020	SELL	$37.87 - $45.37 $5.35 Million - $6.41 Million	-141,273 Reduced 6.67%	1,977,747 $89.4 Million
Q3 2019 Nov 14, 2019	BUY	$40.31 - $43.45 $6.78 Million - $7.31 Million	168,204 Added 8.62%	2,119,020 $86.2 Million
Q2 2019 Aug 14, 2019	SELL	$34.91 - $42.98 $107 Million - $132 Million	-3,067,616 Reduced 61.13%	1,950,816 $83.8 Million
Q1 2019 May 15, 2019	SELL	$32.91 - $40.75 $6.49 Million - $8.04 Million	-197,334 Reduced 3.78%	5,018,432 $193 Million
Q4 2018 Feb 14, 2019	SELL	$31.73 - $39.04 $85.4 Million - $105 Million	-2,690,576 Reduced 34.03%	5,215,766 $184 Million
Q3 2018 Nov 14, 2018	SELL	$32.83 - $38.63 $68.9 Million - $81 Million	-2,097,171 Reduced 20.96%	7,906,342 $304 Million
Q2 2018 Aug 14, 2018	BUY	$26.84 - $34.32 $33.8 Million - $43.2 Million	1,258,287 Added 14.39%	10,003,513 $327 Million
Q1 2018 May 15, 2018	SELL	$25.2 - $28.54 $22.5 Million - $25.5 Million	-894,632 Reduced 9.28%	8,745,226 $239 Million
Q4 2017 Feb 14, 2018	BUY	$24.79 - $29.8 $49.4 Million - $59.4 Million	1,991,739 Added 26.04%	9,639,858 $239 Million
Q3 2017 Nov 14, 2017	BUY	$26.26 - $29.17 $201 Million - $223 Million	7,648,119	7,648,119 $223 Million

Others Institutions Holding BSX

# of Institutions

1,542

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.

Account

Putnam Investments LLC Boston Scientific Corp Transaction History